Available to Current Clients Only

Prescription Required

PRASCEND for horses is the most proven treatment available to control the clinical signs associated with PPID in horses.¹ Pituitary pars intermedia dysfunction (PPID), also referred to as equine Cushing’s disease, is one of the most common endocrine disorders in horses. Signs of PPID can be subtle, but the disease can be serious. 

PRASCEND contains 1 mg pergolide for horses, as pergolide mesylate, a dopamine receptor agonist for oral use in horses only. To find out more about Prascend visit prascend.com.

 PRASCEND is contraindicated in horses with hypersensitivity to pergolide mesylate or other ergot derivatives. PRASCEND has not been evaluated in breeding, pregnant or lactating horses.